Fibralign Corporation
Union City, CA
- UEI
- SKHKN4KZAE48
- CAGE
- 5CXW6
- Primary NAICS
- 339113 Surgical Appliance and Supplies Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 32930 Alvarado-Niles Rd #350, Union City, CA 94587, USA
- Website
- fibralignbio.com
- Founded
- 2007
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| DHA medical, r & d contract sbir 2ND phase II, proposal#: H2-0402, titled, " aligned nanofibrillar scaffold activated… | Medical Command (Army) | $996,609 | |
| New DHP sbir PH II award. | Medical Command (Army) | $987,971 | |
| Sbir phase i DHP H141-009-0112 | Medical Command (Army) | $150,000 | |
| Sbir phase i A113-122-0438 | Medical Command (Army) | $1,149,886 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Prospective evaluation of a surgical solution for breast cancer-associated lymphedema | National Cancer Institute (NIH) | $4,330,246 | |
| Sbir phase i: nanofibrillar scaffolds for tissue engineering | National Science Foundation | $179,964 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Palo Alto Veterans Institute For Research | R01CA285372 | $336,786 | |
| Palo Alto Veterans Institute For Research | HT94252410006 | $55,000 | |
| Palo Alto Veterans Institute For Research | R01CA285372 | $112,262 | |
| Palo Alto Veterans Institute For Research | HT94252410006 | $31,900 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Materic LLC | Baltimore, MD | 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing |
| Lifenet Health | Virginia Beach, VA | 621991 Blood and Organ Banks |
| Epibone, Inc. | New York, NY | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Celdara Medical, LLC | Lebanon, NH | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Memsel Inc. | Fort Worth, TX | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Fibralign Corporation, doing business as Fibralign Inc., is a self-certified small disadvantaged business based in Union City, California, that develops bioengineered therapeutic devices and regenerative medicine scaffolds for federal research programs, operating predominantly as a sub-recipient on federal research grants (67% prime grants, 33% grant sub-awards) with no prime federal contracts.
The vendor's capability portfolio centers on collagen-based conduit and scaffold devices for lymphedema prevention and lymphatic regeneration. Recent work includes a sub-award under the Palo Alto Veterans Institute for Research (prime grantee) for development of a bioengineered therapeutic device targeting lymphedema prevention during cancer surgery, running July 2024 through June 2029, and two related sub-awards for evaluating BioBridgeES scaffold performance in electro-osmotic flow and lymphatic regeneration models in rat models, with the most recent sub-award dated January 2025. The vendor acts as the site investigator and device developer, with scientific lead Michael Paukshto, PhD listed as PI on the primary development sub-award.
Customer concentration is narrow and research-focused. The Department of the Army Medical Command anchors the portfolio with four awards carrying $3.3 million combined potential value, representing 100% of combined potential value in the source data. The Department of Health and Human Services National Institutes of Health National Cancer Institute and the Defense Health Agency each hold two awards, with the National Science Foundation holding one. Work is categorized primarily under research and development in life sciences and biotechnology (R&D PSC codes for medical basic research and advanced development). Fibralign has accumulated $8 million in obligated dollars across nine total awards spanning 2012 to 2025, though the awards-per-year line shows sporadic activity — two awards in 2015 and 2024, one award each in 2017, 2019, and 2025 — suggesting project-driven engagement rather than steady-state contracting volume. No parent contract vehicles, IDIQs, or GWACs appear in the source.
Quick answers
Is Fibralign Corporation registered in SAM.gov?
Yes. Fibralign Corporation's SAM.gov registration is active through November 5, 2026.
What is Fibralign Corporation's most recent federal award?
Fibralign Corporation's most recent federal contract award is DHA medical, r & d contract sbir 2ND phase II, proposal#: H2-0402, titled, " aligned nanofibrillar scaffold activated… (W81XWH19C0021), from Medical Command (Army), on February 7, 2019.
On GovTribe
See Fibralign Corporation's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors